Harm Rutten
Harm Rutten
Hoogleraar Chirurgische oncologie
Verified email at maastrichtuniversity.nl
Title
Cited by
Cited by
Year
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
E Kapiteijn, CAM Marijnen, ID Nagtegaal, H Putter, WH Steup, T Wiggers, ...
New England Journal of Medicine 345 (9), 638-646, 2001
43142001
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
W van Gijn, CAM Marijnen, ID Nagtegaal, EMK Kranenbarg, H Putter, ...
The lancet oncology 12 (6), 575-582, 2011
12422011
The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma
KCMJ Peeters, CAM Marijnen, ID Nagtegaal, EK Kranenbarg, H Putter, ...
Annals of surgery 246 (5), 693-701, 2007
11492007
Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a …
K Peeters, CJH Van De Velde, JWH Leer, H Martijn, JMC Junggeburt, ...
Journal of clinical oncology 23 (25), 6199-6206, 2005
8412005
Risk factors for anastomotic failure after total mesorectal excision of rectal cancer
K Peeters, R Tollenaar, CAM Marijnen, E Klein Kranenbarg, WH Steup, ...
British Journal of Surgery 92 (2), 211-216, 2005
7892005
Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial
CAM Marijnen, CJH Van De Velde, H Putter, M Van Den Brink, CP Maas, ...
Journal of clinical oncology 23 (9), 1847-1858, 2005
6322005
Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands
E Kapiteijn, H Putter, CJH Van de Velde
British journal of surgery 89 (9), 1142-1149, 2002
5012002
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum
CJH van de Velde, PG Boelens, JM Borras, JW Coebergh, A Cervantes, ...
European journal of cancer 50 (1), 1. e1-1. e34, 2014
3492014
Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer: prospective randomised trial with standard operative and …
E Kapiteijn, EK Kranenbarg, WH Steup, CW Taat, HJT Rutten, T Wiggers, ...
The European journal of surgery 165 (5), 410-420, 1999
3201999
Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy
MP Schijven, A Vingerhoets, HJT Rutten, GAP Nieuwenhuijzen, ...
European Journal of Surgical Oncology (EJSO) 29 (4), 341-350, 2003
3092003
Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population‐based study
VE Lemmens, YL Klaver, VJ Verwaal, HJ Rutten, JWW Coebergh, ...
International Journal of Cancer 128 (11), 2717-2725, 2011
2562011
Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial
M Kusters, CAM Marijnen, CJH Van de Velde, HJT Rutten, MJ Lahaye, ...
European Journal of Surgical Oncology (EJSO) 36 (5), 470-476, 2010
2522010
A multivariate analysis of limiting factors for stoma reversal in patients with rectal cancer entered into the total mesorectal excision (TME) trial: a retrospective study
M den Dulk, M Smit, KCMJ Peeters, EMK Kranenbarg, HJT Rutten, ...
The lancet oncology 8 (4), 297-303, 2007
2432007
Controversies of total mesorectal excision for rectal cancer in elderly patients
HJT Rutten, M den Dulk, VEPP Lemmens, CJH van de Velde, ...
The lancet oncology 9 (5), 494-501, 2008
2412008
Comorbidity in older surgical cancer patients: influence on patient care and outcome
MLG Janssen-Heijnen, HAAM Maas, S Houterman, VEPP Lemmens, ...
European Journal of Cancer 43 (15), 2179-2193, 2007
2322007
Risk factors for sexual dysfunction after rectal cancer treatment
MM Lange, CAM Marijnen, CP Maas, H Putter, HJ Rutten, AM Stiggelbout, ...
European Journal of Cancer 45 (9), 1578-1588, 2009
2292009
The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
A Fariņa-Sarasqueta, G Van Lijnschoten, E Moerland, GJ Creemers, ...
Annals of Oncology 21 (12), 2396-2402, 2010
2282010
The Dutch surgical colorectal audit
NJ Van Leersum, HS Snijders, D Henneman, NE Kolfschoten, GA Gooiker, ...
European Journal of Surgical Oncology (EJSO) 39 (10), 1063-1070, 2013
2232013
Internal control over financial reporting and managerial rent extraction: Evidence from the profitability of insider trading
HA Skaife, D Veenman, D Wangerin
Journal of Accounting and Economics 55 (1), 91-110, 2013
2182013
Risk factors for faecal incontinence after rectal cancer treatment
MM Lange, M Den Dulk, ER Bossema, CP Maas, K Peeters, HJ Rutten, ...
British journal of surgery 94 (10), 1278-1284, 2007
2162007
The system can't perform the operation now. Try again later.
Articles 1–20